J&amp;J sees no antitrust roadblocks to Guidant deal
6925
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) on Thursday said it does not see any significant antitrust roadblocks getting in the way of its $25.4 billion acquisition of medical device maker Guidant Corp.
95065
Credit Suisse First Boston maintained &quot;neutral&quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson &amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at $76.
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
568349
Johnson &amp; Johnson, the world&#39;s biggest maker of medical devices, may buy defibrillator maker Guidant Corp. for $24 billion, people familiar with the situation said today.
39205
WASHINGTON, June 11 (Dow Jones) â The Justice Department said on Monday that the proposed merger between Chicago Mercantile Exchange Holdings and Chicago Board of Trade Holdings would not pose a threat to competition.
173356
Johnson & Johnson will buy Guidant  Corp. for $23.9 billion in cash and stock, giving the  health-care products maker a foothold in the fast-growing  market for implantable devices that regulate heartbeats, J&J  said on Wednesday.
336179
LONDON: Johnson &amp; Johnson has agreed to acquire Guidant Corp for US$25.4bil, adding electrical devices for treating heart disease to a line-up of thousands of health products ranging from Band-Aids to cardiac stents.
329296
Stocks stalled at the open Tuesday as investors shrugged off the impact of weaker crude prices and reports that Johnson &amp; Johnson is seeking to buy Guidant in a $24 billion deal.
48544
New Brunswick (dpa) -Johnson &amp; JOhnson, one of the world&#39;s largest pharmaceutical and medical devices producers, is buying Guidant Corporation for 25.4 billion dollars, Johnson &amp; JOhnson said Thursday.
72369
Johnson &amp; Johnson (J&amp;J) agreed yesterday to acquire Guidant Corporation for $25.4 billion (R147 billion), adding electrical devices for treating heart disease to
429216
Drug giant Johnson & Johnson is working on a $24bn purchase of medical device firm Guidant Corp, a key player in the heart technology market.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
160352
Health care and consumer products maker Johnson & Johnson is in negotiations to acquire medical-device maker Guidant Corp., sources familiar with the situation said on Tuesday.
134189
Johnson & Johnson  on Wednesday said it agreed to buy Guidant Corp. , for &#36;25.4 billion in cash and stock, giving the healthcare products maker a foothold in the fast-growing market for implantable devices that regulate heartbeats.
164672
European regulators said on Tuesday they do not intend objecting to the proposed merger of Euronext and the NYSE, removing a hurdle to the completion of the $10 billion transatlantic alliance.
521877
INDIANAPOLIS - New Jersey-based health care products giant Johnson &amp; Johnson is buying Guidant Corp., one of the world&#39;s top makers of cardiac devices, for about $25.4 billion in cash and stock.
466964
NEW YORK Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, one of the largest US makers of devices to treat heart and circulatory illnesses, according to executives close to the talks.